These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2068179)

  • 21. High-performance liquid chromatography: applications in a children's hospital.
    Soldin SJ
    Adv Chromatogr; 1982; 20():139-66. PubMed ID: 6293278
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neuroblastoma in children: clinical and biological aspects. An experience of screening in France].
    Mathieu P; Favrot M; Frappaz D; Chauvin F; Greffe J; Montegue A; Lacroix C; David L; Brunat-Mentigny M; Philip T
    Ann Biol Clin (Paris); 1993; 51(7-8):665-88. PubMed ID: 8166384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between urinary excretion of vanilmandelic acid (VMA) and clinical progress in 15 cases of neuroblastoma].
    Takada H; Inui A; Imashuku S; Kusunoki T; Sawada A
    Nihon Shonika Gakkai Zasshi; 1971 Oct; 75(10):917-23. PubMed ID: 5169739
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroblastoma: the case for screening infants in North America.
    Woods WG; Tuchman M
    Pediatrics; 1987 Jun; 79(6):869-73. PubMed ID: 3588142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life.
    Kerbl R; Urban C; Starz I; Ambros IM; Strehl S; Kovar H; Gadner H; Ambros PF
    Med Pediatr Oncol; 1993; 21(9):625-6. PubMed ID: 8412992
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
    LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
    Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
    [No Abstract]   [Full Text] [Related]  

  • 27. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
    CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
    Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F; Hashizume K; Nakajo T; Kamoshita S
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.
    Mahoney NR; Liu GT; Menacker SJ; Wilson MC; Hogarty MD; Maris JM
    Am J Ophthalmol; 2006 Oct; 142(4):651-9. PubMed ID: 17011859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory techniques and neuroblastoma screening.
    Sawada T
    Lancet; 1988 Nov; 2(8620):1134-5. PubMed ID: 2903341
    [No Abstract]   [Full Text] [Related]  

  • 34. The Labrosse spot test in the diagnosis of neuroblastoma.
    Tay JS; Wee PH; Wong HB; Jacob E
    J Singapore Paediatr Soc; 1979; 21(1-2):56-9. PubMed ID: 548635
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Neuroblastoma.
    Lancet; 1975 Feb; 1(7903):379-80. PubMed ID: 46522
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma.
    Hirata T; Tatara H; Zaizen Y; Suita S; Matsuzaki A; Ueda K
    J Clin Ultrasound; 1995 Jun; 23(5):305-13. PubMed ID: 7642769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for neuroblastoma: progress and pitfalls.
    Ross JA; Davies SM
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):189-94. PubMed ID: 10067819
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Eur J Pediatr; 1988 Apr; 147(3):308-11. PubMed ID: 3391225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.